Bill

Bill > HB1344


OK HB1344

OK HB1344
Prescriptions for off-label medications; terms; moral, ethical, or religious exemptions; immunity from liability; good- faith effort; temporary privileges; at-home and outpatient dispensing; disciplinary action; exceptions; World Health Organization; effective date.


summary

Introduced
02/03/2025
In Committee
02/04/2025
Crossed Over
Passed
Dead

Introduced Session

2025 Regular Session

Bill Summary

An Act relating to prescriptions for off-label medications; defining terms; authorizing prescribing off-label prescriptions; allowing for moral, ethical, or religious exemptions; providing for immunity from liability; providing for good-faith effort; providing for temporary privileges; providing for at-home and outpatient dispensing; prohibiting disciplinary action; providing exceptions to disciplinary action; proscribing the World Health Organization jurisdiction in this state; providing for codification; and providing an effective date.

AI Summary

This bill introduces comprehensive provisions regarding off-label medication prescriptions in Oklahoma, establishing clear guidelines for healthcare professionals. The legislation defines key terms like "off-label drug" (a FDA-approved medication prescribed for a different medical purpose), and establishes that prescribers can issue prescriptions for off-label drugs after obtaining informed consent from patients, their parents/guardians, or healthcare power of attorney holders. The bill allows pharmacists and healthcare facilities to dispense off-label medications with certain protections, including moral, ethical, or religious exemptions and immunity from liability when dispensing drugs in good faith. Healthcare professionals are protected from disciplinary action for prescribing or dispensing off-label medications, except in cases of recklessness or gross negligence. The bill also explicitly prohibits the World Health Organization from having jurisdiction in Oklahoma and prevents state agencies from implementing WHO guidelines that would restrict off-label drug prescriptions. Notably, the bill does not require patients to have specific test results or prior exposure to a disease before receiving an off-label prescription, and it provides a mechanism for patients to access potentially life-saving treatments in challenging medical situations, such as allowing outside physicians to obtain temporary privileges in hospitals to prescribe off-label drugs. The legislation will become effective on November 1, 2025.

Sponsors (1)

Last Action

Second Reading referred to Rules (on 02/04/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...